Please use this identifier to cite or link to this item:
http://repository.tma.uz/xmlui/handle/1/3195
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Mukhammadiyeva S.M., Bekenova G.T., Abdiyeva YU.A. | - |
dc.date.accessioned | 2022-10-11T11:43:29Z | - |
dc.date.available | 2022-10-11T11:43:29Z | - |
dc.date.issued | 2022-03 | - |
dc.identifier.other | DOI prefix: 10.52325 | - |
dc.identifier.uri | http://repository.tma.uz/xmlui/handle/1/3195 | - |
dc.description.abstract | Objective: To study the effectiveness of vitamin D (alphacalcidol) in the treatment of osteoporosis (OP) in patients with ankylosing spondylitis (AS). Results. 52 patients with OP identified AS were divided into 2 groups: group 1 - 24 patients receiving alphacalcidol 0.5-1 mcg "Mineralf", group 2 - 28 patients receiving 1000 mg of calcium. All indications were re-examined before and 6 months after treatment. When patients were treated with alphacalcidol for 6 months, bone and spine pain decreased by 27.2% (Ð <0.001) and muscle strength increased by 16.1% (R <0.05). In the control group, no positive clinical results were observed. Patients responded well to alphacalcidol. Side effects were almost non-existent. Only 1 patient had hypercalcemia at a dose of 1 mcg per day, and another had a headache. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Berlin, Germany | en_US |
dc.subject | ankylosing spondylitis, osteoporosis, calcium supplement, vitamin D. | en_US |
dc.title | Effectiveness of vitamin D in the treatment of bone remodeling in ankilozing spondyloarthritis | en_US |
dc.type | Article | en_US |
Appears in Collections: | Thesis, Articles |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
6.Мухаммадиева С.М._статья хорижий_02-ejmm-vol22.pdf | статья | 842.92 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.